Ukunyibilika ngokukhawuleza kwamahlwili egazi kuxhomekeke kakhulu kunyango ngamayeza. Kwezinye iimeko, kusetyenziswa i-thrombectomy yotyando.
Oku kulandelayo yintshayelelo eneenkcukacha:
1 Ukususwa kwe-thrombolysis yamayeza
1.1 Amayeza asetyenziswa rhoqo
I-Urokinase: yi-enzyme yendalo ekhutshwa kumchamo womntu okanye eyenziwe ziiseli zezintso. Ingasebenza ngokuthe ngqo kwinkqubo ye-fibrinolytic ye-endogen, isebenze i-plasminogen ibe yi-plasmin, ngaloo ndlela inyibilikise amahlwili egazi.
I-Streptokinase: yiproteni ekhutshwe kulwelo lwe-culture lwe-hemolytic streptococci. Ingabopha kwi-plasminogen ukuze yenze i-complex, ikhuthaze ukuguqulwa kwe-plasminogen ibe yi-plasmin, ize emva koko inyibilikise amahlwili egazi.
I-recombinant tissue plasminogen activator (rt-PA): i-glycoprotein enokwenza i-plasminogen isebenze kwaye inobuhlobo obuphezulu ne-fibrin. Ingasebenza ngokukhetha kwi-fibrin kwi-blood clots ukuze yonakalise kwaye ifezekise injongo yokunyibilikisa amahlwili egazi. Xa ithelekiswa ne-urokinase kunye ne-streptokinase, i-rt-PA isebenza kakuhle kwi-thrombolytic kwaye inengxaki ezimbalwa zokopha.
1.2 Ixesha lonyango
Kwizifo ezifana ne-acute myocardial infarction kunye ne-cerebral infarction, ixesha lonyango lwe-thrombolytic libaluleke kakhulu. Ngokubanzi, izigulane ezine-acute myocardial infarction kufuneka zifumane unyango lwe-thrombolytic kwiiyure ezili-12 emva kokuqala, kungcono kwiiyure ezi-3-6; izigulane ezine-acute cerebral infarction zikwixesha legolide le-thrombolysis kwiiyure ezi-4.5-6 emva kokuqala.
2 Ukususwa kwe-thrombectomy kunye nokususwa kwe-thrombectomy ngotyando
2.1 Utyando lwe-thrombectomy olungenelelayo
Phantsi kwesikhokelo se-digital subtraction angiography (DSA), isixhobo se-thrombectomy sithunyelwa kwindawo ye-thrombus nge-catheter ukuze kususwe ngqo i-thrombus. Le ndlela ineengenelo zokulimala okuncinci kunye nokuchacha ngokukhawuleza, kwaye ifanelekile kwezinye izigulana ezingakwaziyo ukunyamezela i-thrombolysis yamayeza okanye ezineziphumo ezimbi ze-thrombolysis yamayeza.
2.2 Utyando lokususa i-thrombectomy
Sika imithambo yegazi ngokuthe ngqo ngotyando ukuze ususe i-thrombus. Le ndlela isetyenziswa rhoqo kwiimeko ezingxamisekileyo apho i-thrombolysis yamayeza kunye ne-thromboectomy yokungenelela ingenakwenziwa okanye isiphumo sibi, njenge-acute lower limb artery embolism. I-thrombectomy yotyando inokubuyisela ukuhamba kwegazi ngokukhawuleza, kodwa ukwenzakala kotyando kukhulu kwaye kukho iingxaki ezininzi emva kotyando.
Nokuba yeyiphi na indlela ekhethiweyo, unyango lomntu ngamnye lufuneka phantsi kwesikhokelo sikagqirha ngokusekelwe kwimeko ethile yesigulana, njengendawo, ubungakanani, ixesha lokwakheka kwe-thrombus, kunye nemeko yomzimba yesigulana iyonke. Kwangaxeshanye, emva kwe-thrombolysis okanye i-thrombectomy, unyango olulandelayo lwe-anticoagulation, i-antiplatelet kunye nolunye unyango luyafuneka ukuthintela ukwakheka kwakhona kwe-thrombus.
I-BEIJING SUCCEEDER TECHNOLOGY INC.
UXINGO LWENKONZO YOKUXINANA
ISICELO SEZIXAKI ZOKUHLAZIYA
I-Beijing Succeeder Technology Inc.(ikhowudi yesitokhwe: 688338) ibisoloko ibandakanyeka kakhulu kwicandelo lokuxilongwa kwe-coagulation ukususela oko yasekwa ngo-2003, kwaye izimisele ukuba yinkokeli kweli candelo. Ikomkhulu layo liseBeijing, inkampani ineqela eliqinileyo le-R&D, imveliso kunye neqela lokuthengisa, eligxile ekuveliseni izinto ezintsha kunye nokusetyenziswa kwetekhnoloji yokuxilonga i-thrombosis kunye ne-hemostasis.
Ngenxa yamandla ayo abalaseleyo obuchwephesha, iSucceeder iphumelele iipatenti ezingama-45 ezigunyazisiweyo, kuquka iipatenti zokuyila ezili-14, iipatenti zemodeli yokusetyenziswa ezili-16 kunye neepatenti zoyilo ezili-15. Le nkampani ikwanazo nezatifikethi zobhaliso lwemveliso yezixhobo zonyango zeKlasi yesiBini ezingama-32, izatifikethi zokufaka iifayile zeKlasi yoku-1 ezi-3, kunye nesatifikethi se-EU CE kwiimveliso ezili-14, kwaye iphumelele isatifikethi senkqubo yolawulo lomgangatho se-ISO 13485 ukuqinisekisa ukugqwesa kunye nokuzinza komgangatho wemveliso.
I-Succeeder ayisiyo nje kuphela ishishini eliphambili leBeijing Biomedicine Industry Leapfrog Development Project (G20), kodwa ikwaphumelele kwiBhodi yoBuchule beSayensi neTekhnoloji ngo-2020, ifezekisa uphuhliso oluphezulu lwenkampani. Okwangoku, inkampani yakhe inethiwekhi yokuthengisa kuzwelonke egubungela amakhulu eearhente kunye neeofisi. Iimveliso zayo zithengiswa kakuhle kwiindawo ezininzi zelizwe. Ikwakhulisa ngokukhutheleyo iimarike zaphesheya kwaye iphucula rhoqo ukhuphiswano lwayo lwamazwe ngamazwe.
Uthando lwabathengi!
I-BEIJING SUCCEEDER TECHNOLOGY INC.
КОНЦЕНТРАЦИЯ СЕРВИС КОАГУЛЯЦИЯ ДИАГНОСТИКА
АНАЛИЗАТОР РЕАГЕНТОВ ПРИМЕНЕНИЕ
I-BEIJING SUCCEEDER TECHNOLOGY INC.
КОНЦЕНТРАЦИЯЛЫҚ ҚЫЗМЕТ КАГУЛЯЦИЯЛЫҚ ДИАГНОЗ
АНАЛизатор РЕАГЕНТТЕРІН ҚОЛДАНУ
I-BEIJING SUCCEEDER TECHNOLOGY INC.
UXINGO LWENKONZO YOKUXINANA
ISICELO SEZIXAKI ZOKUHLAZIYA
Ikhadi leshishini
I-WeChat yesiTshayina